Note: Calypte Biomedical's revenues are gauged from an analysis of company filings.
Calypte Biomedical's Income Statement (based on Industry Averages)
Calypte Biomedical P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Calypte Biomedical is developing and marketing.
Calypte Biomedical doesn't have any recent trademark applications, indicating Calypte Biomedical is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
TESTING FOR THE GREATER GOOD Medical testing services, namely, rendering immunoassays for others in the field of in vitro diagnostic tests and urine-tests for detection of sexually transmitted diseases
04/05/2001
SENTINEL Medical apparatus used for the detection, diagnosis and screening of sexually transmitted and other infectious diseases, namely, diagnostic testing kits consisting of biochemical solutions which can detect the presence of HIV-1 antibodies in urine specimens
12/01/1997
See all trademarks and details in the Full Report.
These companies are in the same general field as Calypte Biomedical and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.